CRISPR-Cas9-based Strategies for Acute Lymphoblastic Leukemia Therapy

Defeating cancer as leukemia has been an up and down challenge. However, leukemia must be treated from the roots. Nowadays, the CRISPR-Cas9 system provided scientists the ability to manipulate the genetic information to correct mutations, rewrite genetic code, or edit immune cells for immunotherapy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Becerra, Edgardo, Ontiveros, Valeria J. Soto, García‑Alcocer, Guadalupe
Formato: Capítulo de libro
Lenguaje:inglés
Publicado: IntechOpen 2022
Materias:
Acceso en línea:https://www.intechopen.com/chapters/84127
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!